Schedule I - Income Statement (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Profit (loss) [abstract] | |||
| Other operating income | $ 82,835 | $ 84,378 | $ 100,992 |
| Staff costs | (270,649) | (279,864) | (305,859) |
| Other operating expense | (245,899) | (265,182) | (270,090) |
| Depreciation and amortization | (84,951) | (75,463) | (73,532) |
| Finance income | 3,474 | 7,248 | 5,422 |
| Finance costs | (20,775) | (21,942) | (38,793) |
| Exchange differences | (23,886) | 13,565 | (7,551) |
| Impairment loss (gain) | (17,488) | (43,052) | (25,290) |
| (Loss) profit before tax | (174,644) | 37,052 | 156,018 |
| Income tax benefit (expense) | (2,468) | (16,252) | (57,540) |
| Total Profit for the year | (177,112) | 20,800 | 98,478 |
| Separate | |||
| Profit (loss) [abstract] | |||
| Other operating income | 15,919 | 20,905 | 28,799 |
| Other operating expense | (27,872) | (34,512) | (36,221) |
| Depreciation and amortization | (130) | (126) | (123) |
| Finance income | 253 | 889 | 31,982 |
| Finance costs | (7,002) | (6,477) | (19,638) |
| Exchange differences | (2,161) | 447 | 86 |
| Impairment loss (gain) | 429 | ||
| (Loss) profit before tax | (20,993) | (18,874) | 5,314 |
| Income tax benefit (expense) | 367 | 115 | |
| Total Profit for the year | $ (20,993) | $ (18,507) | $ 5,429 |
| X | ||||||||||
- Definition The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|